Histologic transformation of lung cancer during pembrolizumab therapy: A case report

Immune checkpoint inhibitors that block the programmed death 1/programmed death ligand 1 pathways are widely used to treat advanced lung cancers. There are seldom cases of histologic transformation reported after treatment with immunotherapy. Here, we report the case of a 69‐year‐old man with stage...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Xiaoyan Si, Yan You, Xiaotong Zhang, Hanping Wang, Mengzhao Wang, Li Zhang
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Wiley 2020-03-01
Seri Bilgileri:Thoracic Cancer
Konular:
Histologic transformation
immune checkpoint inhibitor
non‐small cell lung cancer
pembrolizumab
small cell lung cancer
Online Erişim:https://doi.org/10.1111/1759-7714.13312
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller